Bristol Myers Squibb - Global Biopharmaceutical Company

graphic 3D image with purple and blue cells

News & Perspectives

Bristol Myers Squibb awarded prestigious honour for being the first employer to gain triple-region Menopause Friendly Accreditation >

Lung cancer experts address unwarranted variation in diagnosis and treatment >

Bristol Myers Squibb expands health equity grant initiatives to improve health outcomes >

Cancer Equals: UK wide research highlights differences in cancer care >

NEXT

Sustainability >

Joint working >

Financial disclosures >

Medical information for healthcare providers >

Our Therapy Areas >

NO-GB-2600112
Date of preparation: October 2026